"The BPOM issued the EUA for the Sinopharm covid-19 vaccine on Thursday," BPOM Head Penny Lukito said during a press conference here on Friday.
According to her, the EUA issuance was based on the evaluation results.
"The vaccine has met the requirements. The safety aspect of the Sinopharm vaccine is good. The side effects can be tolerated," she explained.
In a bid to accelerate and expand the coverage of covid-19 vaccination in order to achieve immunity faster, the Government has launched the Gotong Royong Covid-19 Vaccination Program (covid-19 vaccination in mutual cooperation.
Organized by state-owned enterprises, the program will use covid-19 vaccines from Sinopharm, Gamaleya and CanSino.